GW1929

GW1929 is an agonist of PPAR used in studies of Hormone Signaling and Metabolic Signaling. It is especially relevant in cardiovascular, endocrinology, and metabolism models, where defined compound exposure can be linked to ligand-dependent transcriptional programs and endocrine regulation and metabolic regulation, energy sensing, and enzyme-linked homeostasis.

By activating PPAR, GW1929 can be used to examine ligand-dependent transcriptional programs and endocrine regulation and metabolic regulation, energy sensing, and enzyme-linked homeostasis. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In cardiovascular, endocrinology, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving PPAR
• Pathway perturbation studies connected to Hormone Signaling and Metabolic Signaling
• Agonist-response and downstream signaling studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, GW1929 is appropriate when a defined chemical perturbant is needed to connect PPAR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular, endocrinology, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.